Physician profile
Allison Laurel Rand
NPI 1891949442
$695.97
in general payments reported to CMS, 2019-2025
12 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $10.78 · 2022: $41.52 · 2023: $59.78 · 2024: $73.63 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397 · Education: $87.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $397.22 |
| Education | $87.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $289.79 | 2024-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa, Ce-Marked Kxla System |
| Mallinckrodt Hospital Products INC. | $185.91 | 2022-2025 | Acthar |
| Johnson & Johnson Surgical Vision, INC. | $58.21 | 2019 | |
| Eyevance Pharmaceuticals LLC | $34.09 | 2019 | |
| Shire North American Group INC | $33.11 | 2019 | |
| Bausch & Lomb Americas INC. | $23.58 | 2023 | Miebo |
| Aerie Pharmaceuticals, INC. | $21.81 | 2019 | |
| Dompe US, INC. | $14.56 | 2022 | |
| Abbvie INC. | $12.60 | 2022 | |
| Alcon Research LLC | $11.53 | 2019 | |
| Biotissue Holdings INC. | $10.78 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Rand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.